Key Insights

Highlights

Treatment Research

1 treatments under study, led by Drug Treatment Of Myasthenia Gravis And Treatment Of Crisis

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06617741Recruiting

Myasthenia Gravis Foundation of America Global MG Patient Registry

NCT05214612Unknown

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

Showing all 2 trials

Research Network

Common Treatments

  • Drug Treatment Of Myasthenia Gravis And Treatment Of Crisis1

Active Sponsors

  • Alira Health1
  • Assiut University1
  • Myasthenia Gravis Foundation of America1

Top Investigators

Related Conditions

  • Myasthenia Gravis Ocular2
  • Myasthenia Gravis Generalized2
  • Myasthenia Gravis With Exacerbation Disorder2
  • Myasthenia Gravis Crisis2
  • Myasthenia Gravis2

Activity Timeline